About Evangelos Vergetis
Evangelos Vergetis is a president and director at Epikast.
Evangelos Vergetis reports to the SEC as a director or officer of 1 public company: Eucrates Biomedical Acquisition (EUCR).
Evangelos Vergetis first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Evangelos Vergetis in the role, so the role may have started earlier or lasted longer.
EC
Eucrates Biomedical Acquisition Corp.
President, COO and director
2020 · Public company (EUCR)
Key Colleagues at Startups
The people Evangelos Vergetis works with at each company, as listed on that company's latest Form D.
Epikast Inc. · Form D, Feb 5, 2026
BP
Brad Prosek
Director
ON
Oleg Nodelman
Director
SP
Stelios Papadopoulos
Director
DK
Daphne Karydas
Director
AT
Alexandros Tzoukas
Director
DP
Dimitrios Papalexopoulos
Director